MAXIMUS (MMS) Issues FY18 Earnings Guidance

MAXIMUS (NYSE:MMS) issued an update on its FY18 earnings guidance on Thursday morning. The company provided EPS guidance of $3.30-3.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.12. The company issued revenue guidance of $2.48-2.55 billion, compared to the consensus revenue estimate of $2.52 billion.

Shares of MAXIMUS (NYSE:MMS) opened at $65.24 on Thursday. The company has a market capitalization of $4,224.52, a P/E ratio of 20.52, a price-to-earnings-growth ratio of 2.43 and a beta of 1.21. MAXIMUS has a one year low of $51.74 and a one year high of $72.71.

MAXIMUS (NYSE:MMS) last posted its quarterly earnings data on Thursday, November 9th. The health services provider reported $0.81 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.77 by $0.04. The firm had revenue of $620.90 million during the quarter, compared to the consensus estimate of $606.86 million. MAXIMUS had a return on equity of 23.97% and a net margin of 8.54%. analysts predict that MAXIMUS will post 3.05 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 28th. Shareholders of record on Thursday, February 15th will be paid a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a yield of 0.28%. The ex-dividend date is Wednesday, February 14th. MAXIMUS’s dividend payout ratio is presently 5.66%.

Several analysts have commented on MMS shares. Canaccord Genuity reduced their price objective on MAXIMUS from $62.00 to $61.00 and set a hold rating for the company in a research note on Friday, November 10th. Zacks Investment Research raised MAXIMUS from a sell rating to a hold rating in a research note on Wednesday, January 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The company has an average rating of Hold and an average price target of $65.60.

In other MAXIMUS news, CEO Richard A. Montoni sold 30,000 shares of the business’s stock in a transaction that occurred on Thursday, December 7th. The stock was sold at an average price of $69.25, for a total transaction of $2,077,500.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, General Counsel David Francis sold 3,900 shares of the business’s stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $63.97, for a total value of $249,483.00. Following the transaction, the general counsel now owns 15,090 shares in the company, valued at approximately $965,307.30. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 71,417 shares of company stock valued at $4,902,785. 3.10% of the stock is owned by company insiders.

WARNING: “MAXIMUS (MMS) Issues FY18 Earnings Guidance” was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at


MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Earnings History and Estimates for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with's FREE daily email newsletter.

Leave a Reply